Edition:
United States

Iovance Biotherapeutics Inc (IOVA.OQ)

IOVA.OQ on NASDAQ Stock Exchange Global Market

13.60USD
20 Jun 2018
Change (% chg)

$0.10 (+0.74%)
Prev Close
$13.50
Open
$13.65
Day's High
$13.75
Day's Low
$13.18
Volume
136,958
Avg. Vol
235,460
52-wk High
$19.80
52-wk Low
$4.45

Chart for

About

Iovance Biotherapeutics, Inc., formerly Lion Biotechnologies, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. The Company's lead program... (more)

Overall

Beta: 5.10
Market Cap(Mil.): $1,201.21
Shares Outstanding(Mil.): 89.64
Dividend: --
Yield (%): --

Financials

  IOVA.OQ Industry Sector
P/E (TTM): -- 235.76 33.88
EPS (TTM): -1.39 -- --
ROI: -44.25 -5.45 13.21
ROE: -44.25 -6.94 15.18

BRIEF-Iovance Biotherapeutics Announces Pricing Of Its Public Offering Of $150 Million Of Common Stock

* IOVANCE BIOTHERAPEUTICS, INC. ANNOUNCES PRICING OF ITS PUBLIC OFFERING OF $150 MILLION OF COMMON STOCK

Jan 25 2018

BRIEF-Iovance Announces Preliminary Phase 2 Data For Til Treatment In Head And Neck And Cervical Cancers

* IOVANCE BIOTHERAPEUTICS ANNOUNCES PRELIMINARY PHASE 2 DATA FOR TIL TREATMENT IN HEAD AND NECK AND CERVICAL CANCERS

Jan 24 2018

BRIEF-Iovance Biotherapeutics‍ Intends To Offer And Sell $125 Mln Of Its Common Stock

* IOVANCE BIOTHERAPEUTICS, INC. ANNOUNCES PUBLIC OFFERING OF COMMON STOCK

Jan 24 2018

BRIEF-Iovance Biotherapeutics Files For Mixed Shelf Of Up To $250 Mln

* IOVANCE BIOTHERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $250 MILLION - SEC FILING Source text: (http://bit.ly/2zKJhqw) Further company coverage:

Dec 28 2017

Earnings vs. Estimates